Lignocaine vs Bupivacaine Infiltration for Postpartum Perineal Pain After Vaginal Delivery With Episiotomy in Primigravidae

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorAin Shams University

About this trial

In this study, we will compare the effect and safety of lignocaine versus bupivacaine infiltration for postpartum perineal pain after vaginal delivery with episiotomy in primigravidae.

Eligibility criteria

Qualifiers

Primigravidae with the full term undergoing vaginal delivery with episiotomy.

Pregnancies and singleton vertex cephalic fetuses.

In the active phase of the first stage of labor.

Disqualifiers

Patients with history of drug allergies to study drugs as this will increase the risk of complications.

Patients undergoing vaginal delivery under epidural or spinal anesthesia as they will affect post-operative pain and interfere with assessment of efficacy of local infiltration of the study drugs.

Evidence of local infection at site of injection as this will interfere with the action of the study drug and will increase the risk of complications.

Inability to cooperate as this will affect our assessment.

Trial design

Treatments tested in this trial

  • Lignocaine
  • Bupivacaine

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators